Cargando…
A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA
The study was conducted to ascertain whether the quantification of circulating cell-free DNA (cfDNA) in serum has value as a diagnostic or for monitoring the progression of non-small cell lung cancer (NSCLC). The serum/plasma cfDNA concentration was quantified by absolute qPCR of long interspersed n...
Autores principales: | Wei, Lirong, Wu, Wangxi, Han, Liming, Yu, Weimo, Du, Yuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144435/ https://www.ncbi.nlm.nih.gov/pubmed/30250538 http://dx.doi.org/10.3892/ol.2018.9198 |
Ejemplares similares
-
5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018) -
Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer
por: Soliman, Shimaa El-Shafey, et al.
Publicado: (2018) -
Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer
por: Ai, Bo, et al.
Publicado: (2016) -
Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2022) -
The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)